CESSATECH A/S DK -20 (8GN) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.025x

Based on the latest financial reports, CESSATECH A/S DK -20 (8GN) has a cash flow conversion efficiency ratio of -0.025x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-300.00K ≈ $-350.73K USD) by net assets (€12.16 Million ≈ $14.21 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See CESSATECH A/S DK -20 balance sheet independence to measure how much of total assets are equity-financed.

CESSATECH A/S DK -20 - Cash Flow Conversion Efficiency Trend (2021–2025)

This chart illustrates how CESSATECH A/S DK -20's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check CESSATECH A/S DK -20 (8GN) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

CESSATECH A/S DK -20 Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of CESSATECH A/S DK -20 ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Krungthai Car Rent and Lease Public Company Limited
BK:KCAR
0.119x
Swiss Water Decaffeinated Coffee Inc
TO:SWP
0.092x
Shah Metacorp Limited
NSE:SHAH
-0.450x
Blackboxstocks Inc
NASDAQ:BLBX
-0.090x
Investment and Trading of Real Estate JSC
VN:ITC
N/A
DynaCERT Inc.
TO:DYA
2.389x
Augwind Energy Tech Storage Ltd
TA:AUGN
-0.081x
Ruanyun Edai Technology Inc. Ordinary shares
NASDAQ:RYET
-0.043x

Annual Cash Flow Conversion Efficiency for CESSATECH A/S DK -20 (2021–2025)

The table below shows the annual cash flow conversion efficiency of CESSATECH A/S DK -20 from 2021 to 2025. For the full company profile with market capitalisation and key ratios, see 8GN company net worth.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 €12.16 Million
≈ $14.21 Million
€-17.58 Million
≈ $-20.55 Million
-1.446x -66.04%
2024-12-31 €8.27 Million
≈ $9.67 Million
€-7.21 Million
≈ $-8.43 Million
-0.871x -108.37%
2023-12-31 €-1.92 Million
≈ $-2.24 Million
€-19.97 Million
≈ $-23.35 Million
10.406x +1772.25%
2022-12-31 €23.86 Million
≈ $27.89 Million
€-14.85 Million
≈ $-17.36 Million
-0.622x -61.62%
2021-12-31 €26.24 Million
≈ $30.68 Million
€-10.10 Million
≈ $-11.81 Million
-0.385x --

About CESSATECH A/S DK -20

F:8GN Germany Biotechnology
Market Cap
$43.44 Million
€37.15 Million EUR
Market Cap Rank
#22813 Global
#2002 in Germany
Share Price
€2.00
Change (1 day)
-11.50%
52-Week Range
€1.27 - €3.30
All Time High
€3.47
About

Cessatech A/S, a pivotal-stage pediatric biotech company, develops specialty hospital medicines for children in Denmark. Its lead candidate product is CT001, a fixed-dose nasal spray for treating acute pain in children. The company also develops CT002, a non-invasive intranasal sedation for children undergoing medical procedures in Phase 2 clinical trials; and CT003, a topical anesthetic in pre-c… Read more